Nektar Therapeutics (NASDAQ:NKTR)

CAPS Rating: 2 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Recs

0
Player Avatar murray2253 (< 20) Submitted: 12/3/2007 1:12:34 PM : Underperform Start Price: $6.66 NKTR Score: -10.94

APPLIC OF MEDS THROUGH LUNGS --- ???

Featured Broker Partners


Advertisement